Wednesday, April 23, 2014

Wal-Mart seeks overseas success by going native in China

Zhong Guoyan sifted through piles of fish at a Wal-Mart in Shenzhen, one of China's largest cities. She studied the fins, making sure they were intense red and firm. She peered at the eyeballs were they bulging?

" When I come here, I take a look," she stated. "If it's good, then I will buy it. If it's only cheap, I won't buy it."

In American Wal-Marts, customers don't get to fondle their fish. But America is not China, as the world's biggest retailer has learned. If the Arkansas-based company wishes to win over foreign consumers, it has to shed a few of its American methods, and accommodate extremely various custom-made and conventions that are fast altering.



Sunday, April 20, 2014

Canada's finance minister satisfies young Ottawa business owners

Just back from the G7 summit and on his way to The House of Commons, Minister of Finance Bill Morneau just recently dropped in to visit business display screens produced by Ottawa’s youngest business owners.

4 hundred students from 17 regional schools brought their items and their marketing savvy to the annual Entrepreneurial Adventure showcase at The Canadian Museum of History.

From the minute the very first groups shown up in the early morning, the foyer ended up being a center of enjoyment. Students decorated their tables and their areas with screen boards, banners, sample items, lights and video. No effort or information was too small to be ignored in the competitors for the audience s choice award.

Friday, March 14, 2014

Icahn gets a 'large position' in Botox-maker Allergan

Carl Icahn revealed a "big position" in Ireland-based Allergan (AGN) on Tuesday, virtually two months after the United States government obstructed its $160 billion merger with Pfizer by releasing brand-new rules versus tax inversions.

Allergan's stock cost at first jumped 3 percent after the premarket statement, but was up about 1.25 percent in early trading. For more information visit

Icahn expressed support for Allergan CEO Brent Saunders.